About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
ACAD - ACADIA Pharmaceutica...| Previous Close | $47.44 | Open | |
| Volume | Market Cap | 7.513B | |
| Yield | Last Dividend |
| J.P. Morgan Stick to Their Buy Rating fo... | 03/01/21 |
| J.P. Morgan Stick to Their Buy Rating for ACADIA Pharmaceuticals Inc | |
| Canaccord Genuity Stick to Their Buy Rat... | 02/26/21 |
| Canaccord Genuity Stick to Their Buy Rating for ACADIA Pharmaceuticals Inc | |
| Acadia Pharmaceuticals Reports Fourth Qu... | 02/24/21 |
| SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced financial results for the fourth quarter and full year ended De... | |
| A Preview Of ACADIA Pharmaceuticals's Ea... | 02/23/21 |
| On Wednesday, February 24, ACADIA Pharmaceuticals (NASDAQ:ACAD) will release its latest earnings report. Check out Benzinga's preview to understand th... | |
| Acadia Pharmaceuticals Recognizes Nation... | 02/19/21 |
| SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the launch of MoreThanMemoryLoss.com, a new website with educat... | |
| Acadia Pharmaceuticals to Present at Upc... | 02/18/21 |
| SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at the following investor conferences:... | |
| Acadia Pharmaceuticals to Announce Fourt... | 02/10/21 |
| SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report fourth quarter and full year 2020 financial... | |
| Mizuho Securities Stick to Their Buy Rat... | 01/27/21 |
| Mizuho Securities Stick to Their Buy Rating for ACADIA Pharmaceuticals Inc | |
| Acadia Pharmaceuticals Announces Commerc... | 01/27/21 |
| SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Michael Yang, Executive Vice President and Chief Commercia... | |
| Oppenheimer Stick to Their Hold Rating f... | 01/14/21 |
| Oppenheimer Stick to Their Hold Rating for ACADIA Pharmaceuticals Inc | |
| RBC Capital Stick to Their Buy Rating fo... | 01/14/21 |
| RBC Capital Stick to Their Buy Rating for ACADIA Pharmaceuticals Inc | |
| Shuman Glenn & Stecker Investigates Acad... | 01/11/21 |
| DENVER???(BUSINESS WIRE)???Shuman Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directo... | |
| Insider Selling: ACADIA Pharmaceuticals ... | 01/10/21 |
| ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) President Srdjan R. Stankovic sold 1,725 shares of ACADIA Pharmaceuticals stock in a transaction that occurr... | |
| Acadia Pharmaceuticals to Present at the... | 11/10/20 |
| SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the Stifel 2020 Virtual Healthcare Conf... | |
| RBC Capital Stick to Their Buy Rating fo... | 11/05/20 |
| RBC Capital Stick to Their Buy Rating for ACADIA Pharmaceuticals Inc | |
| Canaccord Genuity Stick to Their Buy Rat... | 11/05/20 |
| Canaccord Genuity Stick to Their Buy Rating for ACADIA Pharmaceuticals Inc | |
| ACADIA Pharmaceuticals Wall street estim... | 11/04/20 |
| ACADIA Pharmaceuticals announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??... | |
| Acadia Pharmaceuticals to Present New Sc... | 10/26/20 |
| SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that scientific presentations highlighting new analyses of pima... | |
| ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD... | 10/22/20 |
| ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) CEO Stephen Davis sold 2,960 shares of the firm???s stock in a transaction dated Friday, October 16th. The s... | |
| Acadia Pharmaceuticals to Announce Third... | 10/21/20 |
| SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report third quarter financial results on Wednesda... | |
| Michael J. Yang Sells 1,247 Shares of AC... | 10/21/20 |
| ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) EVP Michael J. Yang sold 1,247 shares of ACADIA Pharmaceuticals stock in a transaction that occurred on Frid... | |
| Srdjan R. Stankovic Sells 1,297 Shares o... | 10/21/20 |
| ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) President Srdjan R. Stankovic sold 1,297 shares of ACADIA Pharmaceuticals stock in a transaction on Friday, ... | |
| Stephen Davis Sells 2,960 Shares of ACAD... | 10/19/20 |
| ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) CEO Stephen Davis sold 2,960 shares of the business???s stock in a transaction dated Friday, October 16th. T... | |
| The Lewy Body Dementia Association and A... | 10/14/20 |
| ATLANTA & SAN DIEGO--(BUSINESS WIRE)--The Lewy Body Dementia Association (LBDA) and Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today an excl... | |
| Acadia Pharmaceuticals Appoints Elizabet... | 10/01/20 |
| SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Elizabeth (Betsy) Garofalo, M.D. to its Boar... | |
| ACADIA Pharmaceuticals to Present at Upc... | 09/02/20 |
| SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at the following upcoming virtual inve... | |
| Acadia Pharmaceuticals Acquires CerSci T... | 08/31/20 |
| Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to ad... | |
| ACADIA Pharmaceuticals Appoints Gudarz D... | 08/31/20 |
| SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Dr. Gudarz Davar as Executive Vice President... | |
| ACADIA Pharmaceuticals Acquires CerSci T... | 08/25/20 |
| SAN DIEGO & FORT WORTH, Texas--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the acquisition of CerSci Therapeutics, a c... | |
| ACADIA Pharmaceuticals to Present at The... | 08/12/20 |
| SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at The JMP Securities CNS Forum on Wednesd... | |
| Strong Buy rating | 02/25/21 |
| Morgan Stanley maintains Overweight rating and raises Price Target from $60.00 to $65.00 | |
| Buy rating | 12/16/20 |
| Mizuho initiates coverage with Buy rating and announces Price Target of $69.00 | |
| Strong Buy rating | 12/16/20 |
| Morgan Stanley maintains Overweight rating and raises Price Target from $58.00 to $60.00 | |
| Date | 2021-02-24 (AMC) | Est. (EPS/Rev.) | ($0.47)/ 123.2M |
| Actual (EPS/Rev.) | $-0.42/ $121.01 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Arbitrage Trade Analytics | Royce Wells | 72.00 % | Subscribe |
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
| Best Trading Ideas | Best Trading Ideas | 54.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
